In human glioblastoma (GBM) tumor cells, knockdown of RBBP4 causes sensitization of tumor cells to temozolomide (TMZ) chemotherapy and supresses the expression of several DNA repair genes, including RAD51, a key enzyme of the homologous recombination repair pathway (54). Here, RAD51 is linked to glioblastoma.